Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B T S Thirumamagal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ultramicroscopy|March 9, 2010
Synthesis and morphological characterization of block copolymers for improved biomaterialsScott Schricker, Manuel Palacio, B T S Thirumamagal, et al.
Journal of Medicinal Chemistry|September 1, 2006
Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumorsYoungjoo Byun, B T S Thirumamagal, Weilian Yang, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 2, 2002
2-[1-(Phenylsulfonyl)ethyl]benzoic acid and 2-[1-(phenylsulfonyl)propyl]benzoic acidK Sethu Sankar, D Velmurugan, B T S Thirumamagal, et al.
Molecular Cancer Therapeutics|September 20, 2005
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculatureMarina V Backer, Timur I Gaynutdinov, Vimal Patel, et al.
Nucleosides, Nucleotides & Nucleic Acids|August 12, 2006
Boronated thymidine analogues for boron neutron capture therapyB T S Thirumamagal, Jayaseharan Johnsamuel, Guirec Y Cosquer, et al.
Bioorganic & Medicinal Chemistry|July 13, 2006
Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancerSureshbabu Narayanasamy, B T S Thirumamagal, Jayaseharan Johnsamuel, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 17, 2004
Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomasWeilian Yang, Rolf F Barth, Gong Wu, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 17, 2004
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agentRolf F Barth, Gong Wu, Weilian Yang, et al.
Bioconjugate Chemistry|September 21, 2006
Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT)B T S Thirumamagal, Xiaobin B Zhao, Achintya K Bandyopadhyaya, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ultramicroscopy|March 9, 2010
Synthesis and morphological characterization of block copolymers for improved biomaterialsScott Schricker, Manuel Palacio, B T S Thirumamagal, et al.
Journal of Medicinal Chemistry|September 1, 2006
Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumorsYoungjoo Byun, B T S Thirumamagal, Weilian Yang, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 2, 2002
2-[1-(Phenylsulfonyl)ethyl]benzoic acid and 2-[1-(phenylsulfonyl)propyl]benzoic acidK Sethu Sankar, D Velmurugan, B T S Thirumamagal, et al.
Molecular Cancer Therapeutics|September 20, 2005
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculatureMarina V Backer, Timur I Gaynutdinov, Vimal Patel, et al.
Nucleosides, Nucleotides & Nucleic Acids|August 12, 2006
Boronated thymidine analogues for boron neutron capture therapyB T S Thirumamagal, Jayaseharan Johnsamuel, Guirec Y Cosquer, et al.
Bioorganic & Medicinal Chemistry|July 13, 2006
Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancerSureshbabu Narayanasamy, B T S Thirumamagal, Jayaseharan Johnsamuel, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 17, 2004
Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomasWeilian Yang, Rolf F Barth, Gong Wu, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 17, 2004
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agentRolf F Barth, Gong Wu, Weilian Yang, et al.
Bioconjugate Chemistry|September 21, 2006
Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT)B T S Thirumamagal, Xiaobin B Zhao, Achintya K Bandyopadhyaya, et al.
Pageof 1